FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely to efferent treatment methods, and can be used for viral infection treatment. Therefor there are disclosed versions of method and an apparatus. The method includes blood or plasma sampling thereafter run through a porous hollow-filament membrane wherein lectin molecules are immobilised in a porous membrane exterior. The apparatus includes a processing chamber for blood or plasma sampling with contained lectin, and a porous membrane wherein blood or plasma cells cannot run through said membrane and contact with lectin.
EFFECT: inventions ensure effective isolating viral particles from blood or plasma due to substance molecules not being specifically affined to a target molecule, but contacting high-mannose viral glycoproteins or their fragments.
33 cl, 8 dwg, 10 ex
| Title |
Year |
Author |
Number |
| METHOD OF PREPARING HCV PROTEINS USEFUL FOR USING IN VACCINE OR IMMUNE ANALYSIS, ASIALOGLYCOPROTEIN (VARIANTS), COMPOSITION FOR USING IN VACCINE OR IN IMMUNE ANALYSIS (VARIANTS), METHOD OF ASIALOGLYCOPROTEIN PURIFICATION AND A METHOD OF HCV CONTENT DECREASE OR ELIMINATION |
1991 |
- Robert O.Rehlston
- Frehnk Markus
- Kent B.Tud'Jum
- Barbara A.Gervehjs
- Dzhon A.Kholl
|
RU2123528C1 |
| HEPATITIS C VIRUS (HCV) ASIALOGLYCOPROTEIN, IMMUNOGENIC COMPOSITION, METHOD OF INDUCTION OF IMMUNE RESPONSE, METHOD OF IMMUNE ASSAY |
1991 |
- Rehlston Robert O.
- Markus Frehnk
- Tud'Jum Kent B.
- Gervehjs Barbara A.
- Kholl Dzhon A.
|
RU2175657C2 |
| IMMUNOGENIC COMPOSITION AND METHOD OF FUSED PROTEIN VACCINE DEVELOPMENT |
2004 |
|
RU2407749C2 |
| RAPID SELECTION METHOD FOR HIV GP-120 VARIANTS |
2012 |
- Juste Errans Marija Eloiza
- Sanches Merino Viktor
- Ferrejra Karolina
|
RU2603732C2 |
| IMMUNOGENIC COMPOSITION AND METHOD OF ELABORATION OF VACCINE BASED ON PSORALEN-INACTIVATED HIV |
2004 |
|
RU2401665C2 |
| ANTIVIRAL AGENT, VACCINE BASED ON THEREOF, METHOD OF ITS PREPARING, THERAPEUTIC AGENT AND METHOD OF DETECTION OF RNA-VIRUSES |
1990 |
- Derek Stjuart[Gb]
- Dzhon Marshall Skott Forrest[Gb]
- Verner Mjuller[De]
|
RU2082417C1 |
| IMMUNOGENIC COMPOSITION BASED ON CONDITIONALLY LIVE VIRION AND METHOD FOR MAKING THEREOF |
2006 |
|
RU2415933C2 |
| GENETIC CONSTRUCT FOR GENE EXPRESSION mNG_CD4-CXCR4, RECOMBINANT PLASMID rVSV_MNG_CD4-CXCR4 AND A RECOMBINANT VESICULAR STOMATITIS VIRUS STRAIN rVSV_mNG_CD4-CXCR4, WHICH PROVIDES TARGETED VIROLYSIS OF CELLS EXPOSING HIV-1 GP120/GP41 PROTEINS TROPISM X4 ON THEIR SURFACE |
2021 |
- Bochkareva Mariya Dmitrievna
- Imatdinov Ilnaz Ramisovich
- Imatdinov Almaz Ramisovich
- Sulgina Tatyana Vladimirovna
- Tishin Anton Evgenevich
- Sulgin Aleksandr Andreevich
- Prudnikova Elena Yurevna
- Gavrilova Elena Vasilevna
- Maksyutov Rinat Amirovich
|
RU2768032C1 |
| HUMANIZED ANTIBODY AND METHOD OF PREPARATION THEREOF, POLYNUCLEOTYL (VERSIONS), AND HYBRIDON CELL LINE (VERSIONS) |
1993 |
|
RU2134724C1 |
| GENETIC CONSTRUCT FOR EXPRESSION OF mNG_CD4-CCR5 GENES, RECOMBINANT PLASMID rVSV_mNG_CD4-CCR5 AND RECOMBINANT STRAIN OF VESICULAR STOMATITIS VIRUS rVSV_mNG_CD4-CCR5 PROVIDING TARGETED VIROLYSIS OF CELLS DISPLAYING HIV-1 PROTEINS GP120/GP41 OF R5 TROPISM ON THEIR SURFACE |
2021 |
- Bochkareva Mariya Dmitrievna
- Imatdinov Ilnaz Ramisovich
- Imatdinov Almaz Ramisovich
- Sulgina Tatyana Vladimirovna
- Tishin Anton Evgenevich
- Sulgin Aleksandr Andreevich
- Prudnikova Elena Yurevna
- Gavrilova Elena Vasilevna
- Maksyutov Rinat Amirovich
|
RU2769125C1 |
